Company profile: Cellipont
1.1 - Company Overview
Company description
- Provider of cell therapy CDMO services specializing in cell therapy development and small-to-large batch production.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Cellipont
Galenicum
HQ: Spain
Website
- Description: Provider of pharmaceutical products and services, including R&D, regulatory affairs, manufacturing, licensing, and global supply across technologies from injectables to oral solids and nasal sprays. Operates a facility near Madrid producing over 50 million packs annually, trades APIs, and markets Vitae bioequivalent medicines and Galenicum Derma specialty dermatology products; applies QbD standards in development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Galenicum company profile →
Societal CDMO
HQ: United States
Website
- Description: Provider of contract development and manufacturing services focused on small molecule therapies, including drug product formulation development; clinical and commercial manufacturing of solid and liquid products (including controlled substances and high-potency molecules); analytical development and QC testing; clinical trial packaging and labeling; and regulatory consulting and FDA submission support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Societal CDMO company profile →
Continuum Clinical
HQ: United States
Website
- Description: Provider of Health Economics and Outcomes Research services and clinical trial engagement solutions, including the MERIS Total Engagement suite for participant and site support with real-time performance data; patient recruitment campaigns; Global Site Solutions; study/site support; retention solutions; and patient advocacy and diversity & inclusion services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Continuum Clinical company profile →
BioStrata
HQ: United Kingdom
Website
- Description: Provider of life science marketing services delivered by a team fluent in scientific and business languages, including brand awareness, lead generation and customer conversion; scientific and technical content creation; SEO (keyword research, content optimization, performance tracking); public relations; and marketing strategy development based on market research and tactical planning.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioStrata company profile →
Evotec
HQ: Germany
Website
- Description: Provider of drug discovery and gene therapy solutions, delivering CRO/CDMO services from initial research to clinical trials; AI-powered PanOmics and iPSC technologies for disease understanding in small molecules and biotherapeutics; hit identification; J.POD continuous biomanufacturing for biologics; and a proprietary ion channel assay.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Evotec company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Cellipont
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Cellipont
2.2 - Growth funds investing in similar companies to Cellipont
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Cellipont
4.2 - Public trading comparable groups for Cellipont
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →